Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modafinil for impaired consciousness in hospitalized patients with COVID-19
IRCT20170903036041N3Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in coronavirus disease 2019 (COVID-19) comparing Modafinil with Placebo (2 arms). Primary endpoint: Level of consciousness. Started May 2021; status: completed.
02
Drugs
modafinil
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20170903036041N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170903036041N3.